Richest NFL Team Owners List: Who’s Most Connected to Stock Market?
The list of NFL team owners includes billionaires and families. Some of them are well connected to publicly traded companies.
Stocks · News reference
Reported September 8, 2026: 'Tylenol Use In Pregnancy May Be Linked With Uterus, Ovary Changes In Daughters' - Reuters News
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s
Eli Lilly's Immunology division generated $2.6 billion in revenues in H1 2026, up 9% year-over-year, representing 6.1% of total revenues. Led by Taltz, the portfolio is expanding through newer products like Ebglyss and Omvoh, plus strategic acquisitions of DICE, Morphic, and Merida to strengthen its pipeline across IBD, autoimmune diseases, and allergies. However, the company faces intense competition from established players and newer therapies.
Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food
President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Morris and other companies, agreeing to divest if confirmed.
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
Vanguard's VHT and State Street's XPH offer different approaches to healthcare investing. VHT provides broad sector exposure with lower costs (0.09% expense ratio) and higher dividend yield (1.5%), making it ideal for long-term investors. XPH focuses on pharmaceuticals with higher volatility but stronger 1-year returns (57.2% vs 29.3%), appealing to growth-oriented investors willing to accept greater risk.
Shares of consumer staples companies are trading lower as elevated energy prices increase the chances of a Fed rate hike in September, which may slow consumer demand, boost borrowing costs and crimp margins.
Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead
Kenvue has secured shareholder approval and U.S. antitrust clearance for its planned Q4 2026 combination with Kimberly-Clark. However, the deal faces ongoing risks including weak Self Care segment performance, $8.5B debt burden, margin pressures from inflation and tariffs, restructuring costs, and pending litigation. Q2 results showed 3% sales growth but EPS missed estimates with adjusted gross margin declining 70 basis points.